Therapeutic targeting of the thermogenesis and orexigenic or anorexigenic pathways that are regulated by the FTO and TUB genes respectively has important clinical implications for the obesity epidemic especially in ethnic minorities. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.